161 related articles for article (PubMed ID: 28414128)
1. Impaired degradation of medullary WNK4 in the kidneys of KLHL2 knockout mice.
Kasagi Y; Takahashi D; Aida T; Nishida H; Nomura N; Zeniya M; Mori T; Sasaki E; Ando F; Rai T; Uchida S; Sohara E
Biochem Biophys Res Commun; 2017 May; 487(2):368-374. PubMed ID: 28414128
[TBL] [Abstract][Full Text] [Related]
2. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
3. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
[TBL] [Abstract][Full Text] [Related]
4. Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic Hypertension.
Zhang C; Meermeier NP; Terker AS; Blankenstein KI; Singer JD; Hadchouel J; Ellison DH; Yang CL
Biochem Biophys Res Commun; 2016 Jan; 469(1):44-48. PubMed ID: 26607111
[TBL] [Abstract][Full Text] [Related]
5. KLHL2 interacts with and ubiquitinates WNK kinases.
Takahashi D; Mori T; Wakabayashi M; Mori Y; Susa K; Zeniya M; Sohara E; Rai T; Sasaki S; Uchida S
Biochem Biophys Res Commun; 2013 Aug; 437(3):457-62. PubMed ID: 23838290
[TBL] [Abstract][Full Text] [Related]
6. Kelch-Like Protein 2 Mediates Angiotensin II-With No Lysine 3 Signaling in the Regulation of Vascular Tonus.
Zeniya M; Morimoto N; Takahashi D; Mori Y; Mori T; Ando F; Araki Y; Yoshizaki Y; Inoue Y; Isobe K; Nomura N; Oi K; Nishida H; Sasaki S; Sohara E; Rai T; Uchida S
J Am Soc Nephrol; 2015 Sep; 26(9):2129-38. PubMed ID: 25556166
[TBL] [Abstract][Full Text] [Related]
7. Decreased KLHL3 expression is involved in the activation of WNK-OSR1/SPAK-NCC cascade in type 1 diabetic mice.
Guo Q; Zhang Y; Jiang GR; Zhang C
Pflugers Arch; 2021 Feb; 473(2):185-196. PubMed ID: 33432425
[TBL] [Abstract][Full Text] [Related]
8. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
Sohara E; Uchida S
Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
[TBL] [Abstract][Full Text] [Related]
9.
Sasaki E; Susa K; Mori T; Isobe K; Araki Y; Inoue Y; Yoshizaki Y; Ando F; Mori Y; Mandai S; Zeniya M; Takahashi D; Nomura N; Rai T; Uchida S; Sohara E
Mol Cell Biol; 2017 Apr; 37(7):. PubMed ID: 28052936
[TBL] [Abstract][Full Text] [Related]
10. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
[TBL] [Abstract][Full Text] [Related]
11. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.
Shibata S; Zhang J; Puthumana J; Stone KL; Lifton RP
Proc Natl Acad Sci U S A; 2013 May; 110(19):7838-43. PubMed ID: 23576762
[TBL] [Abstract][Full Text] [Related]
12. Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain.
Lin CM; Cheng CJ; Yang SS; Tseng MH; Yen MT; Sung CC; Lin SH
FASEB J; 2019 Jan; 33(1):1051-1061. PubMed ID: 30148674
[TBL] [Abstract][Full Text] [Related]
13. Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo.
Yoshida S; Araki Y; Mori T; Sasaki E; Kasagi Y; Isobe K; Susa K; Inoue Y; Bomont P; Okado T; Rai T; Uchida S; Sohara E
Clin Exp Nephrol; 2018 Dec; 22(6):1251-1257. PubMed ID: 29869755
[TBL] [Abstract][Full Text] [Related]
14. Decrease of WNK4 ubiquitination by disease-causing mutations of KLHL3 through different molecular mechanisms.
Mori Y; Wakabayashi M; Mori T; Araki Y; Sohara E; Rai T; Sasaki S; Uchida S
Biochem Biophys Res Commun; 2013 Sep; 439(1):30-4. PubMed ID: 23962426
[TBL] [Abstract][Full Text] [Related]
15. Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension.
Wakabayashi M; Mori T; Isobe K; Sohara E; Susa K; Araki Y; Chiga M; Kikuchi E; Nomura N; Mori Y; Matsuo H; Murata T; Nomura S; Asano T; Kawaguchi H; Nonoyama S; Rai T; Sasaki S; Uchida S
Cell Rep; 2013 Mar; 3(3):858-68. PubMed ID: 23453970
[TBL] [Abstract][Full Text] [Related]
16. Structural and biochemical characterization of the KLHL3-WNK kinase interaction important in blood pressure regulation.
Schumacher FR; Sorrell FJ; Alessi DR; Bullock AN; Kurz T
Biochem J; 2014 Jun; 460(2):237-46. PubMed ID: 24641320
[TBL] [Abstract][Full Text] [Related]
17. Generation and analysis of pseudohypoaldosteronism type II knock-in mice caused by a nonsense KLHL3 mutation in the Kelch domain.
Lin CM; Sung CC; Yang SS; Chen YC; Huang SM; Lin SH
FASEB J; 2022 Jun; 36(6):e22363. PubMed ID: 35621709
[TBL] [Abstract][Full Text] [Related]
18. Potassium depletion stimulates Na-Cl cotransporter
Ishizawa K; Xu N; Loffing J; Lifton RP; Fujita T; Uchida S; Shibata S
Biochem Biophys Res Commun; 2016 Nov; 480(4):745-751. PubMed ID: 27942049
[TBL] [Abstract][Full Text] [Related]
19. Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.
Cornelius RJ; Si J; Cuevas CA; Nelson JW; Gratreak BDK; Pardi R; Yang CL; Ellison DH
J Am Soc Nephrol; 2018 Nov; 29(11):2627-2640. PubMed ID: 30301860
[TBL] [Abstract][Full Text] [Related]
20. Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation.
Wu G; Peng JB
FEBS Lett; 2013 Jun; 587(12):1717-22. PubMed ID: 23665031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
